Conference Program / DAY1

09:00-09:20
Opening Session Hall 1

Video Address by Her Excellency Dalia Grybauskaitė, President of the Republic of Lithuania

Welcome Address by Saulius Skvernelis, Prime Minister of the Republic of Lithuania

09:20-10:20
Keynote lecture: Structural insights into G protein coupled receptor singalling Hall 1

Prof. Brian K. Kobilka

2012 Nobel Prize Winner in Chemistry

10:20-11:00
Presentation by the Lithuanian Minister of Economy Hall 1

Virginijus Sinkevičius

Lithuanian Minister of Economy

Israel Innovation Authority Hall 1

Dan Kalman Biran

Vice President, International Division, Israel Innovation Authority

11:00-11:30
Poster session / coffee break
11:30-12:50
Session / 1 Mechanism of degenerative and genetic diseases Hall 2
Candidate therapy studies for hereditary cerebral amyloid angiopathies (CCAS) and related neurodegenerative disorders

Dr. Hakon Hakonarson

Director of the Center  for Applied Genomics at the Joseph Stokes Jr. Research Institute of Children’s Hospital of Philadelphia

Expanding the potential of gene editing applications

Dr. Giedrius Gasiūnas

CasZyme, Lithuania

Mechanotransductive L-type calcium channels as a therapeutic target for metabolic modulation of osteoarthritic cartilage

Dr. Eiva Bernotienė

Institute Center for Innovative Medicine, Lithuania

Gaucher disease and Parkinson: from clinical observations to prevention

Prof. Ari Zimran

Shhare Zedek Medical Center and Medical Practice Consultant, Israel

Session / 2 Immuno-oncology treatment – challenges and opportunities. Powered by Thermo Fischer Scientific Hall 1
Industry on the edge: the speed of clinical success in cell therapy and the challenge of commercialization

Dr. Øystein Åmellem

Thermo Fisher Scientific, Norway

The role of cellular and gene therapy in 2018: car-t cell therapy

Dietger Niederwieser

University of Leipzig, Germany

Entrobodiestm: Cell-permeable antibody fragments in oncology

Dr. Priit Kogerman

Lepritech, Estonia

Predicting Immunotherapy response: best clinical practice in oncology

Dr. Ana Finzel Pérez

OncoDNA, Gosselies, Belgium

Session / 3 3D printing in medicine. Powered by Ortho Baltic Hall 3
Breaking the barriers to set patient-specific devices as gold standard in surgery

Dr. Jules Poukens

Hasselt University, University of Leuven, Belgium

Additive manufacturing brings back the subperiosteal implants again for innovative promising treatment

Dr. Andrejus Surovas

Implantatas, Lithuania

Orthopaedic polymer mp-1tm application for 3d printing

Alisa Buchman

MMATECH, Israel

Mesoscale 3d optical lithography for biomedicine

Dr. Mangirdas Malinauskas

Vilnius University, Lithuania

Smart patient-specific cranial implants. combination of 3d printing and sensorics

Maxime Maugeon

PhD candidate, LSMU, KTU, Ortho Baltic, Lithuania

12:50-14:00
LUNCH
14:00-14:30
Plenary: Emerging Technology using magnet for cartilage repair – clinical results Hall 1

Prof. Mitsuo Ochi

President, University of Hiroshima, Japan

14:30-15:00
Plenary: New Molecular tools for epigenome analysis: towards advanced diagnostics of disease Hall 1

Prof. Saulius Klimašauskas

Vilnius University, Lithuania

15:00-15:30
Poster session / Coffee break
15:30-17:00
Session / 4 Personalized medicine and diagnostics Hall 2
Genomics-Driven Biomarker Discovery and Development at CHOP and Applications in Patient Care

Dr. Hakon Hakonarson

Director of the Center  for Applied Genomics at the Joseph Stokes Jr. Research Institute of Children’s Hospital of Philadelphia

Return of research results to participants of Estonian Biobank

Dr. Neeme Tõnisson

Estonian Genome Centre of the University of Tartu, Estonia

Reconstructing the kidney from human IPS cells

Prof. Ryuichi Nishinakamura

Kumamoto University, Japan

Human Pluripotent stem cells: hurdles and needs for application

Prof. Andreas Kurtz

Charite University Medicine Berlin, Germany

The role of modern genomic technologies in precision healthcare

Prof. Lina Basel

Rabin Medical Center, Tel Aviv University, Israel

Session / 5 Digital Health. Powered by SAP Hall 1
Big Data and the Transformation of Healthcare

Dr. Martin Kohn

former CMS at IBM, USA

Anonymized Identificational Technology and its Use in EHR Clinical Trial Patient Recruitment

Ian Rentsch

Clinerion, Switzerland

VR technologies for health

Prof. Tomas Blažauskas

Faculty of Informatics, Kaunas University of Technology, Lithuania

Towards personalized nutrition for health

Aidas Pranculis

OME Health

Session / 6 Stem cells Hall 3
Normal and Neoplastic Stem Cells

Irving Weissman, MD

Director of Institute of Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, USA

Optimization of mesenchymal stem cell manufacturing: the effects of various xeno-free media on cells proliferation, phenotype and differentiation potential

Dr. Jekaterina Kazantseva

Cellin Technology, Estonia

Process Development and Optimization for Mesenchymal Stem Cells Utilizing the Ambr Bioreactor Systems

Quentin Vicard

Sartorius Stedim Biotech, France

Cell therapy for fistulas in Crohn's disease: A long and winding road

Dr. Mariano Garcia-Arranz, PhD

Health Research Institute Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Spain

Session / 7 Towards stronger international cooperation in health research. Info session organized by LINO and MITA Johnson & Jonshon Innovation Hall
15:00 – 15:10 Welcome word

by organizers of info session

15:10 – 16:00 Horizon 2020 calls 2018-2020

SOCIETAL CHALLENGE 1: HEALTH, DEMOGRAPHIC CHANGE AND WELLBEING

Frédéric Suche, Brussels Enterprise Agency

EUROPEAN RESEARCH COUNCIL: STARTING, CONSOLIDATOR, ADVANCED AND SYNERGY GRANTS

Jonas Bunikis, Scientific Office and Panel Coordinator for the Immunity and Infection Panel

MARIE SKŁODOWSKA-CURIE ACTIONS: RESEARCH AND INNOVATION STAFF EXCHANGE AND OTHER OPPORTUNITIES

speaker tbc

16:00 – 16:20 Innovative Medicine Initiative: public-private partnerships

Catherine Brett, IMI

16:20 – 16:50 Health research beyond Horizon 2020

TBC

16:50 – 17:00 Closing remarks

 

 

For more information about the info session and registration please click here.

Charlotte Geerdink, Moderator of the event

Conference program / DAY2

09:00-10:00
Plenary session. Global life sciences ecosystems – trends and key to success Hall 1

Dr. Kai Uwe Bindseil

Cluster Manager for Healthcare Industries in Berlin-Brandenburg – HealthCapital

Prof. Mark Ferguson

Director General, Science Foundation Ireland and Chief Scientific Adviser to the Government of Ireland

Dr. Makoto Suematsu

President, Japan Agency for Medical Research and Development AMED

Henk Joos

Founder, Silver arrow

10:00-10:30
Poster session / Coffee break Hall 1
10:30-12:15
Session / 8 Laser applications in life sciences Hall 2
How to improve disease diagnosis using the combination of lasers and ultrasound?

Mantvydas Jašinskas

EKSPLA, Lithuania

Dynamic optical imaging: from programmable microscopy with SLMs to tunable lenses

Prof. Dr. Monika Ritsch-Marte

Division for Biomedical Optics, Department for Physiology and Medical Physics, Medical University of Innsbruck, Austria

Sub-micro hybrid subtractive-additive 3D fabrication of medical devices using femtosecond laser: towards widespread solution

Linas Jonušauskas

Femtika, Lithuania

Detection of OTC drugs in biological fluids by means of colloidal SERS with near infrared laser excitation

Prof. Valdas Šablinskas

Vilnius university, Lithuania

Tiny self-contained optical engines for cell counting in microfluidics

Evaldas Pabrėža

Integrated Optics, Lithuania

Karolis Leonavičius

Droplet Genomics, Lithuania

Session / 9 Research as an impulse for the industry. Powered by HealthCapital Cluster Hall 1
From bcrt to becat – the path to innovative therapies in regenerative medicine

Prof. dr. med. Petra Reinke

Charité  – Universitätsmedizin Berlin, Germany

Translation of biochemical research into drug design to treat metabolic and neurode-generative diseases

Prof. Dr. Hans-Ulrich Demuth

Fraunhofer Society, Institute for Cell Therapy and Immunology Leipzig, Institute of Bioanalytics and Bioprocesses Postdam-Golm, Germany

Development of innovative pharmaceutical products for advanced pharmacy: science and industry experience

Prof. Jurga Bernatonienė

Lithuanian University of Health Sciences, Lithuania

From Basic Science to Industrial Applications: carbohydrate vaccines and continuous drug production

Prof. Dr. Peter H. Seeberger

Max Planck Institute of Colloids and Interfaces, Germany

Session / 10 ScanBalt Forum. Satellite event Hall 3
09:00-10:00 Baltic sea region macro-regional accelerator and strategy development

Internationalization a top priority – Presentation of ScanBalt stakeholder survey

Annika Kask, Project Manager, ScanBalt fmba

Discussion: The future strategy of ScanBalt fmba

Moderators: Jaanus Pikani, Chairman ScanBalt fmba, Peter Frank, General Secretary, ScanBalt fmba

10:30-11:45 Health IT SME development in the Baltic Sea region

Welcome by moderator

Thomas Frahm, Project director, Life Science Nord

Introduction to BaltCityPrevention

Sami Perälä, Director, EPTEK

BSR as one market – TOP3 to do’s from a company perspective

Didzis Glazitis, CEO, Telemedica

BSR as Health IT investment target – should investors take an interest?

Seppo Makinen, Partner, Pathena Investments

Public Health Authorities – Need for new technologies in prevention?

Elisabet Kivimäki, Into Seinäjoki Oy

Round table: How do we collaborate to make BSR a global hotspot for health IT?
Concluding remarks

Sami Perälä, Director, EPTEK

11:45-12:15 Inspirational talk and discussion: health sector opportunities in South-East Asia: Experience from Vietnam

Inspirational talk by Sulev Kõks, Professor, Tartu University, EATRIS  National Director

Moderator: Jaanus Pikani, Chairman, ScanBalt

 

13:15-14:30 India-EU collaboration on life sciences and the health sector

  • Sharda Balaji, Founder, NovoJuris Legal
  • Paul Lillrank, Professor, Aalto University
  • V K Singh, Managing Director, Innovation-Curis
  • Sachin Gaur, entrepreneur, mobile and internet solutions

12:15-13:15
Lunch
13:00-17:00
STARTUP PITCH CHALLENGE BY JOHNSON & JOHNSON INNOVATION Johnson & Johnson Innovation Hall

INSIDE OUT – A LARGE PHARMA’S VIEW OF THE LITHUANIAN LIFE SCIENCES ECOSYSTEM

Anthony Gemmell, Senior Director, EMEA Network New Ventures & Transactions, Johnson & Johnson Innovation

ENTREPRENEURSHIP IN THE CAMBRIDGE BIOMEDICAL CLUSTER

Chris Lowe, Director of Cambridge Academy of Therapeutic Sciences (CATS) within the University of Cambridge

PITCH BATTLE & AWARD CEREMONY

10 startups will pitch their ideas to investors and public. A judge panel of investors, professors and other life sciences professionals will determine the winners and the best ones will be awarded!

13:15-13:45
Plenary: How Top-Performing Organizations Improve Patient Outcomes Through Digitalization Hall 1

Dr. Clemens Suter-Crazzolara, Chief Product Expert, SAP, German

13:45-14:15
Plenary: The force of digitalization to empower future Healthcare and Life Science Hall 1

Dr. Peter Kjäll, Research Institutes of Sweden, Sweden

14:15-14:30
Coffee break
14:30-16:00
Session / 11 Life Sciences meet technologies for better healthcare solutions. Powered by Sicor Biotech Hall 2
Creating pioneering opportunity in Greater Manchester

Prof. Jackie Oldham

The University of Manchester, United Kingdom

Bioactive materials for advanced pharmaceutical and healthcare solutions

Dr. Aistė Jekabsonė

Lithuanian University of Health Sciences, Neuroscience Institute, Lithuania

Theranostics - complementary engineering and medicine

Prof. Eugenijus Kaniušas

Institute of Electrodynamics, Microwave and Circuit Engineering, Vienna University of Technology, Austria

Impact of Digitisation on Pharmaceutical Manufacturing

Matt Moran

Biopharmachem Ireland, Ireland

Session / 12 Diagnostic technologies Hall 1
Application of ultrasonic technologies for characterization and properties measurement of biological tissues and liquids

Prof. Dr. Renaldas Raišutis

Kaunas University of Technology, Lithuania

Urine liquid biopsy for prostate cancer diagnostics

Julius Gagilas

Diagnolita, Lithuania

Miniaturized and multiplexed diagnostic assays - from R&D to production and market

Paulina Gozdzialska

SCIENION AG, Germany

Independent diagnostic information content of bioelectric and biomagnetic recordings

Prof. Jaakko Malmivuo

Technische Universität Berlin, Germany

New Personal Health Devices for Unobtrusive Monitoring of Chronic Diseases

Prof.  Vaidotas Marozas

Kaunas University of Technology, Lithuania

Session / 13 ScanBalt Forum. Food for thoughts Hall 3
An industry perspective for commercialization of biomarkers

Dr. Janne Koskinen, Research and Development Director of ArcDia International Oy Ltd.

 

Working on both sides of the fence – citizen feedback loops in the public sector

Esther Davidsen, Entrepreneur and Advisor

Charlotte Geerdink, Moderator of the event
Keynote
Prof. Brian Kobilka 2012 Nobel Prize Winner in Chemistry
Keynote
Dr. Clemens Suter-Crazzolara VP Product Management at SAP Health
Keynote
Prof. Mark Ferguson Director General, Science Foundation Ireland and Chief Scientific Adviser to the Government of Ireland
Keynote
Prof. Mitsuo Ochi President, Hiroshima University
Keynote
Prof. Saulius Klimašauskas Institute of Biotechnology, Vilnius University
Guest
Alisa Buchman MMATECH Ltd.
Guest
Ana Finzel Pérez, PhD OncoDNA, Gosselies, Belgium
Guest
Charlotte Geerdink
Guest
Dr. Aistė Jekabsonė Lithuanian University of Health Sciences, Neuroscience Institute
Guest
Dr. Andreas Kurtz Charite University Medicine Berlin
Guest
Dr. Andrejus Surovas Implantatas
Guest
Dr. Eiva Bernotienė State Research Institute Centre for Innovative Medicine
Guest
Dr. Giedrius Gasiūnas Vilnius university / CasZyme
Guest
Dr. Hakon Hakonarson Center of Applied Genomics at the Joseph Stokes Jr., Research Institute of Children's Hospital of Philadelphia
Guest
Dr. Jekaterina Kazantseva Cellin Technologies
Guest
Dr. Kai Uwe Bindseil HealthCapital Cluster
Guest
Dr. Karolis Leonavičius
Guest
Dr. Mangirdas Malinauskas Laser Research Center, Vilnius University
Guest
Dr. Mariano Garcia-Arranz, PhD Health Research Institute Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Spain
Guest
Dr. Martin Kohn
Guest
Dr. Neeme Tõnisson Estonian Genome Centre of the University of Tartu
Guest
Dr. Peter Kjäll
Guest
Dr. Priit Kogerman Lepritech
Guest
Dr. Øystein Åmellem Thermo Fisher Scientific
Guest
Evaldas Pabrėža Integrated Optics
Guest
Henk Joos Silver Arrow, former Managing Director at Flanders Bio
Guest
Ian Rentsch Clinerion
Guest
Irving Weissman, MD Director, Institute of Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine
Guest
Julius Gagilas Diagnolita UAB
Guest
Linas Jonušauskas Femtika
Guest
Mantvydas Jašinskas EKSPLA
Guest
Matt Moran Biopharmachem Ireland
Guest
Maxime Maugeon Baltic Orthoservice
Guest
Paulina Gozdzialska DiagnostikNet-BB
Guest
Prof. Ari Zimran Jerusalem Sha'are Zedek hospital
Guest
Prof. Dietger Niederwieser University of Leipzig
Guest
Prof. Dr. Hans-Ulrich Demuth Fraunhofer Society, Institute for Cell Therapy and Immunology Leipzig, Institute of Bioanalytics and Bioprocesses Potsdam-Golm, Germany
Guest
Prof. Dr. Jaakko Malmivuo Technische Universität Berlin
Guest
Prof. Dr. Peter H. Seeberger Max Planck Insittute of Colloids and Interfaces
Guest
Prof. Dr. med. Petra Reinke Berlin Center for Advanced Therapies (BECAT) Berlin-Brandenburger Center for Regenerative Therapies (BCRT), Charité – Universitätsmedizin Berlin
Guest
Prof. Eugenijus Kaniušas Vienna University of Technology
Guest
Prof. Jacqueline Oldham The University of Manchester, United Kingdom
Guest
Prof. Jurga Bernatonienė Lithuanian University of Health Sciences
Guest
Prof. Lina Basel Rabin Medical Center, Tel Aviv University
Guest
Prof. Monika Ritsch-Marte Director of the Division for Biomedical Optics Department for Physiology and Medical Physics Medical University of Innsbruck
Guest
Prof. Renaldas Raišutis Kaunas University of Technology
Guest
Prof. Ryuichi Nishinakamura Kumamoto University, Japan
Guest
Prof. Tomas Blažauskas Faculty of Informatics, Kaunas University of Technology
Guest
Prof. Vaidotas Marozas Kaunas University of Technology
Guest
Prof. dr. Jules Poukens University Hasselt and Leuven, Belgium Zuyderland Medical Center Sittard, the Netherlands
Guest
Quentin Vicard Sartorius Stedim Biotech
Guest
Valdas Šablinskas Vilnius University